Literature DB >> 11537575

Ocular torsion as a test of the asymmetry hypothesis of space motion sickness.

S G Diamond1, C H Markham.   

Abstract

Disconjugate eye torsion induced by 0 G and 1.8 G during parabolic flight was studied in nine former astronauts in 1990 and eight in 1991, four of whom were included in the previous experiment. The astronauts could be divided into two statistically significant groups on the basis of low and high scores of disconjugacy. When their histories of space motion sickness (SMS) were later revealed, all of the low scorers had not been sick on previous space flights; all the high scorers had had SMS. These data give support to the hypothesis that SMS in one-half or two-thirds of astronauts is due to an otolith, probably utricular, asymmetry in those persons.

Entities:  

Keywords:  NASA Discipline Neuroscience; NASA Discipline Number 16-10; NASA Program Space Physiology and Countermeasures; Non-NASA Center

Mesh:

Year:  1992        PMID: 11537575     DOI: 10.1016/0094-5765(92)90168-i

Source DB:  PubMed          Journal:  Acta Astronaut        ISSN: 0094-5765            Impact factor:   2.413


  4 in total

1.  Prototype tests of vertical and torsional alignment nulling for screening vestibular function.

Authors:  M C Schubert; J Stitz; H S Cohen; H Sangi-Haghpeykar; A P Mulavara; B T Peters; J J Bloomberg
Journal:  J Vestib Res       Date:  2017       Impact factor: 2.435

Review 2.  A review on screening tests for vestibular disorders.

Authors:  Helen S Cohen
Journal:  J Neurophysiol       Date:  2019-04-17       Impact factor: 2.974

3.  Binocular misalignments elicited by altered gravity provide evidence for nonlinear central compensation.

Authors:  Kara H Beaton; W Cary Huffman; Michael C Schubert
Journal:  Front Syst Neurosci       Date:  2015-06-02

4.  Association of Lymphatic Fluid Volume in the Inner Ear of Beagle Dogs with the Susceptibility to Motion Sickness.

Authors:  Mingliang Cai; Lei Cui; Junfeng Xu; Lihua Xu; Chang Ren; Xin Zhou; Zhenglin Jiang
Journal:  J Int Adv Otol       Date:  2022-07       Impact factor: 1.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.